NGEN logo

NervGen Pharma Corp. Common stock

NGEN
Healthcare|Biotechnology|CA
$1.33
+0.01 (+0.76%)
DCF Value
$0.17
Tangible Book / Share
$0.18
Cash / Share
$0.94
Next Earnings Report
Nov 12, 2026
EPS est. -$0.10
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest May 26, 2026 (F-10). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

SEC Filings (32)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 16, 20266-K/AForeign issuer reportDocumentIndex
Oct 16, 202640-F/AAnnual report (foreign)DocumentIndex
Sep 25, 20266-KForeign issuer reportDocumentIndex
Sep 24, 20266-KForeign issuer reportDocumentIndex
Aug 13, 20266-KForeign issuer reportDocumentIndex
Jul 2, 20266-KForeign issuer reportDocumentIndex
Jul 2, 2026SUPPLDocumentIndex
Jun 1, 20266-KForeign issuer reportDocumentIndex
May 26, 2026EFFECTDocumentIndex
May 26, 20266-KForeign issuer reportDocumentIndex
May 26, 2026SUPPLDocumentIndex
May 26, 2026F-XDocumentIndex
May 26, 2026F-10IPO / offering registrationDocumentIndex
May 22, 20266-KForeign issuer reportDocumentIndex
May 22, 2026SUPPLDocumentIndex
May 21, 2026SUPPLDocumentIndex
May 18, 20266-KForeign issuer reportDocumentIndex
May 15, 20266-KForeign issuer reportDocumentIndex
May 7, 2026S-8Employee stock planDocumentIndex
Apr 27, 20266-KForeign issuer reportDocumentIndex
Mar 31, 202640-FAnnual report (foreign)DocumentIndex
Mar 13, 20266-KForeign issuer reportDocumentIndex
Feb 13, 20266-KForeign issuer reportDocumentIndex
Feb 10, 20266-KForeign issuer reportDocumentIndex
Jan 23, 2026S-8Employee stock planDocumentIndex
Jan 8, 20266-KForeign issuer reportDocumentIndex
Jan 7, 2026EFFECTDocumentIndex
Jan 7, 2026CERTDocumentIndex
Jan 7, 20268-A12BDocumentIndex
Jan 7, 2026F-10/AIPO / offering registrationDocumentIndex
Dec 17, 2025F-XDocumentIndex
Dec 17, 2025F-10IPO / offering registrationDocumentIndex